Health & Pharm General

Anatara Lifesciences Ltd (ASX:ANR) CEO Steve Lydeamore to Present at AusBiotech 2020

🕔10/9/2020 3:19:26 PM

Anatara's CEO, Steve Lydeamore will be presenting to investors at AusBiotech + Invest 2020 on 29th October 2020. Register to attend free for qualified investors.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Investor Presentation

🕔9/8/2020 8:28:54 AM

Anatara Lifesciences (ASX:ANR) is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr. Steven Lydeamore, will present today at the ASX Small and Mid-Cap Conference 2020, a virtual conference.

Read Full Article

Bluechiip Ltd (ASX:BCT) Lodgement of Open Briefing

🕔9/2/2020 8:19:43 AM

In this Open Briefing(R), Managing Director, Andrew McLellan discusses Bluechiip's (ASX:BCT) 2020 financial results, the Annual Report and the outlook for 2021.

Read Full Article

Anatara Lifesciences (ASX:ANR) ASX Small and Mid-Cap Conference 2020

🕔9/1/2020 11:33:08 AM

Steven Lydeamore, Chief Executive Officer, Anatara Lifesciences (ASX:ANR) will be presenting at the ASX Small and Mid-Cap Conference 2020.

Read Full Article

Ellis Martin Report: Science Editor Dr. Thomas Glenn and Zhittya Genesis Medicine's Dr. Jack Jacobs.

🕔8/31/2020 1:47:31 PM

In this segment, Dr. Jacobs of Zhittya Genesis Medicine and Ellis Martin are joined by the Science Editor of the Ellis Martin Report, Dr. Thomas Glenn.

Read Full Article

Regeneus Ltd (ASX:RGS) Receives Milestone Payment from Kyocera

🕔8/28/2020 10:06:35 AM

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, is pleased to announce that is has received a payment of 100M JPY (~A$1.3M) from Kyocera Corporation (Kyocera, TYO:6971)

Read Full Article

Bluechiip Ltd (ASX:BCT) Appendix 4E and Annual Report

🕔8/27/2020 4:50:10 PM

The Group reported a consolidated loss after providing for income tax for the financial year ended 30 June 2020 of $4,501,085, compared to a consolidated loss of $3,257,996 for the financial year ended 30 June 2019.

Read Full Article